TREATMENT-NAЇVE MANTLE CELL LYMPHOMA

Clinical trials for TREATMENT-NAЇVE MANTLE CELL LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new TREATMENT-NAЇVE MANTLE CELL LYMPHOMA trials appear

Sign up with your email to follow new studies for TREATMENT-NAЇVE MANTLE CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New hope for lymphoma patients: drug combo shows promise in phase 3 trial

Disease control Completed

This study tested whether adding the drug orelabrutinib to standard chemotherapy (R-CHOP) works better than chemotherapy alone for people with untreated mantle cell lymphoma. Only 3 patients took part. The main goal was to see if the combination delays cancer growth. This is a di…

Matched conditions: TREATMENT-NAЇVE MANTLE CELL LYMPHOMA

Phase: PHASE3 • Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. • Aim: Disease control

Last updated Apr 26, 2026 20:01 UTC

TREATMENT-NAЇVE MANTLE CELL LYMPHOMA

Get alerted when new TREATMENT-NAЇVE MANTLE CELL LYMPHOMA trials appear

New hope for lymphoma patients: drug combo shows promise in phase 3 trial